BrainsWay Secures $20 Million Private Placement with Valor Equity Partners; Shares Rise 12%

BrainsWay (NASDAQ: BWAY) has entered into a private investment financing deal with Valor Equity Partners, a firm renowned for supporting industry leaders such as SpaceX, Tesla, Neuralink, and Harmony Biosciences. This investment brings in gross proceeds of approximately $20 million and will drive BrainsWay’s strategic initiatives, including market expansion, data analysis enhancements, R&D development, and broader access to its Deep TMS™ technology. Valor will also have the right to nominate members to BrainsWay’s board. The $9.51 per ADS purchase price represents a 20% premium over the 30-day average.

Ami Boehm, the Company’s Chairman of the Board, stated, “With this transaction, we will be better positioned to accelerate the growth of our business by tapping into new markets and new revenue channels, including customer types and commercial partnerships. During the past year, we have received several inbound requests from leading investment groups interested in investing in BrainsWay.”

BrainsWay is currently leading the PRISM Emerging Mental Health Index, with shares up 12%.